Deal reflects Liberty Mutual\'s conviction to its focused Asia Pacific strategy BOSTON,March 3,2025-- Liberty Mutual Insurance has agreed to sell its operations in Thailand and Vietnam to Chubb Limit
READ MORESTOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) are approved by FDA for all indications of reference products PROLIA® (denosumab) and XGEVA® (denosumab) respectively[1],[2]
BARCELONA,Spain,March 5,2025-- On March 3,as the global communications and technology community converged in Barcelona,forMWC Barcelona 2025,Yangtze Optical Fibre and Cable Joint Stock Limited Company
BEIJING,Nov. 30,2024-- This is a report fromChina.org.cn:   Do you like the Chinese hotpot? Now Vivi is about to dive into some amazing Sichuan-Chongqing hotpot at the 2n
BEIJING,Nov. 30,2024-- This is a report fromChina.org.cn:   Technology and reality merge at the 2nd China Intl Supply Chain Expo,unlocking endless possibilities for every
Sales Ban Enforced on NUC(Kuvings)\'s Primary Juicer Models on Amazon SEOUL,South Korea,Dec. 2,2024-- Hurom,a global leader in juicing technology as the pioneer of low-speed extraction methods,announc
TOKYO,Dec. 2,2024-- TheSumida-Ryogoku area of Tokyo,famous as the home of sumo,Japan\'s national sport,is home to many famous historical sites that give a glimpse into the country\'s history.In the Ry
BEIJING,Dec. 2,2024-- A news report bychinadiplomacy.org.cn on the 2024 Forum on Dialogue between the Civilizations of China and Latin America and the Caribbean:
HONG KONG,Nov. 29,2024-- AIX Inc. (NASDAQ:AIFU) is a leading company focused on insurance agency and claims services. Recently,the company has been gradually pushing for an intelligent and diversified
BEIJING,Nov. 29,2024-- A news report from China.org.cn:   What does Taiwan mean to China?
ATUSHI,China,Nov. 29,2024--Recently,State Grid Kizilsu Kirghiz Autonomous Prefecture Electric Power Supply Company has actively practiced the service tenet of " PEOPLE POWER FOR THE PEOPLE",
SHANGHAI,Nov. 29,2024-- Recently,ShanghaiMicuRx Pharmaceutical Co.,Ltd. ("MicuRx",688373.SH) announced the successful completion of its Phase III clinical trial of MRX-4 for injection transi
© OfficialAffairs
